China Reports Almost 60,000 Covid-Related Deaths In A Month
(Bloomberg) --
China said almost 60,000 people died at medical institutions from Covid-related causes since early December, offering some clues on the cost of an abrupt and ill-prepared shift of its virus policy.Â
A total of 59,938 deaths were reported at hospitals across the country between Dec. 8 and Jan. 12 linked to Covid-19, according to the National Health Commission on Saturday. Of these, 5,503 died from respiratory failure and 54,435 died from other diseases but were infected with Covid.
China Finds No New Covid Variants But Mutation Threat Lingers
The average age of those who died was 80.3 years and more than 90% of them had other diseases including cardiovascular diseases, advanced tumors and metabolic diseases, the commission said. The number of deaths of the elderly is relatively high because of increased incidence of respiratory diseases and aggravation of cardiovascular diseases in the winters among older people, said Jiao Yahui, an official at the commission. That, coupled with Covid infections, aggravated the situation, Jiao said.Â
It has become increasingly difficult to gauge the impact of Covid in China as authorities stopped the frequent release of data and recently adopted a narrower definition of a Covid fatality — only those who die from respiratory failure caused by the virus are counted.Â
Reports of surging deaths across a swathe of the country on social media suggest the actual number of those who died from the infection may be much higher than the official count.
--With assistance from .
More stories like this are available on bloomberg.com
©2023 Bloomberg L.P.
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
